Literature DB >> 2159435

The seroepidemiology of human herpesvirus-6 (HHV-6) from a case-control study of leukaemia and lymphoma.

D A Clark1, F E Alexander, P A McKinney, B E Roberts, C O'Brien, R F Jarrett, R A Cartwright, D E Onions.   

Abstract

Sera from an epidemiological case-control study of leukaemias and lymphomas conducted between 1980 and 1986 were examined for reactivity to human herpesvirus-6 (HHV-6) by an indirect immunofluorescence assay. Statistical analyses of the data revealed higher HHV-6 seroprevalence and antibody titres in the cases, particularly evident in the disease subtypes acute myeloid leukaemia, Hodgkin's disease (HD), and low-grade non-Hodgkin's lymphoma. Within the control group alone, HHV-6 seroprevalence was placed at 55% at a serum dilution of 1:40. The controls also displayed higher seropositivity in females as compared with males. Further analyses suggest an association of increased HHV-6 seropositivity and geometric mean titre ratio with HD among young adults lacking social contact in the family group. This finding might indicate late exposure to HHV-6 in such persons and could possibly signify late exposure to a number of viruses, including those hypothesized as playing a role in the aetiology of HD. Previous reports have nominated Epstein-Barr virus as a possible candidate. Our results suggest that HHV-6 should be included in further investigations of the aetiology of HD.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2159435     DOI: 10.1002/ijc.2910450507

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  12 in total

Review 1.  Human herpesvirus 6.

Authors:  D K Braun; G Dominguez; P E Pellett
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

Review 2.  Hodgkin's disease and the Epstein-Barr virus.

Authors:  K J Flavell; P G Murray
Journal:  Mol Pathol       Date:  2000-10

3.  Evaluation of a commercial enzyme-linked immunosorbent assay for detection of serum immunoglobulin G response to human herpesvirus 6.

Authors:  T P Sloots; J P Kapeleris; I M Mackay; M Batham; P L Devine
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

4.  Relative seroprevalence of human herpes viruses in patients with chronic lymphocytic leukaemia.

Authors:  C Steininger; L Z Rassenti; K Vanura; K Eigenberger; U Jäger; T J Kipps; C Mannhalter; S Stilgenbauer; T Popow-Kraupp
Journal:  Eur J Clin Invest       Date:  2009-06       Impact factor: 4.686

5.  Latent human herpesvirus-6 DNA is sparsely distributed in peripheral blood lymphocytes of healthy adults and patients with lymphocytic disorders.

Authors:  T Sandhoff; J P Kleim; K E Schneweis
Journal:  Med Microbiol Immunol       Date:  1991       Impact factor: 3.402

6.  Human herpesvirus 6 induces interleukin-1 beta and tumor necrosis factor alpha, but not interleukin-6, in peripheral blood mononuclear cell cultures.

Authors:  L Flamand; J Gosselin; M D'Addario; J Hiscott; D V Ablashi; R C Gallo; J Menezes
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

7.  Antibodies against six human herpesviruses in relation to seven cancers in black South Africans: a case control study.

Authors:  A Berrington de González; M I Urban; F Sitas; N Blackburn; M Hale; M Patel; P Ruff; R Sur; R Newton; V Beral
Journal:  Infect Agent Cancer       Date:  2006-09-14       Impact factor: 2.965

8.  Lack of involvement of known oncogenic DNA viruses in Epstein-Barr virus-negative Hodgkin's disease.

Authors:  A A Armstrong; L Shield; A Gallagher; R F Jarrett
Journal:  Br J Cancer       Date:  1998-04       Impact factor: 7.640

9.  Viral involvement in Hodgkin's disease: detection of clonal type A Epstein-Barr virus genomes in tumour samples.

Authors:  S Gledhill; A Gallagher; D B Jones; A S Krajewski; F E Alexander; E Klee; D H Wright; C O'Brien; D E Onions; R F Jarrett
Journal:  Br J Cancer       Date:  1991-08       Impact factor: 7.640

10.  Hodgkin's lymphoma and infection: findings from a UK case-control study.

Authors:  R Newton; S Crouch; P Ansell; J Simpson; E V Willett; A Smith; C Burton; A Jack; E Roman
Journal:  Br J Cancer       Date:  2007-09-25       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.